1 documents found
Information × Registration Number 0217U000476, 0114U003143 , R & D reports Title To find out new predictors of the course of BCR-ABL negative chronic myeloproliferative neoplasms and to develop principles of risk adapted therapy popup.stage_title Head Maslyak Zvenyslava Volodymyrivna, Registration Date 06-02-2017 Organization LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE popup.description2 In the process of investigation a group of patients with chronic myeloproliferative neoplasms was formed, which included patients with idiopathic and secondary myelofibrosis, essential thrombocythemia and polycythemia vera. One hundreed and forty patients were examined, 67 of them with myelofibrosis, 34 patients with polycytemia vera and 39 patients with essential thrombocytemia. Karyotype of haemopoietic cells was examined using classic cytogetetic technique, and karyotype of haemopoietic precursors circulating in peripheral blood was investigated using improved method of karyotyping. Mutations JAK2V617F and MPL515L/R were detected with real-time polymerase chain reaction; level of proinflammatory and proangiogenic cytokines were determined with immunoassay technique. Prognostic markers were revealed for each of investigated MPN, which adequately reflect the risk of disease progression or development of thrombotic complications. For patients with MF among such factors are unfavorable cytogenetic aberrations, mutation JAK2V617F and high level of proangiogenic factor VEGF. For PV patients among such markers are proangiogenic cytokine VEGF and proinflammatory IL-8. For patients with ET new prognostic markers were revealed: mutation JAK2V617F, proangiogenic factor VEGF and proinflammatory cytokines TNF and IL-8. Treatment principles were proposed for chronic MPN with regard to prognostic factors.54815481 Product Description popup.authors Бойко Ольга Ігорівна Везденко Лідія Орестівна Виговська Ярослава Іллівна Даниш Ольга Йосипівна Кокоруз М. В. Котлярчук Констянтин Богданович Лозинська М. Р. Лозинський Ростислав Юрійович Масляк Звенислава Володимирівна Примак С. В. Сімонова М. І. Тераз С. С. popup.nrat_date 2020-04-02 Close
R & D report
Head: Maslyak Zvenyslava Volodymyrivna. To find out new predictors of the course of BCR-ABL negative chronic myeloproliferative neoplasms and to develop principles of risk adapted therapy. (popup.stage: ). LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE. № 0217U000476
1 documents found

Updated: 2026-03-24